Compare Heron Therapeutics Inc (HRTX) vs Roundhill S&P 500 0DTE Covered Call Strategy ETF (XDTE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heron Therapeutics Inc vs Roundhill S&P 500 0DTE Covered Call Strategy ETF — how do they compare? Heron Therapeutics Inc trades at $0.46 (market cap $91.46M), while Roundhill S&P 500 0DTE Covered Call Strategy ETF trades at $38.67. The key difference: Roundhill S&P 500 0DTE Covered Call Strategy ETF is trading nearer its 52-week high, Heron Therapeutics Inc nearer its low. Which is the better fit depends on your goals.
| HRTX | XDTE | |
|---|---|---|
Market Cap | $91.46M | — |
Sector | Health | Income / Options Overlay |
52-Week High | $1.96 | $44.76 |
52-Week Low | $0.39 | $36.00 |
Enterprise Value | $189.36M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HRTX trades at $0.4804, up 2.06% today, with a bullish technical signal despite mixed earnings. The stock shows a low price-to-sales ratio of 0.51 but negative profitability, with a net income margin of -20.53% in 2026. Recent Q1 2026 earnings missed expectations, though management reaffirmed full-year guidance. Analyst consensus is strongly bullish with 94.7% buy ratings.
Outlook remains speculative given persistent losses and cash burn, but potential upside exists if operational improvements materialize. Key risks include patent litigation outcomes and reliance on revenue growth to achieve profitability. Investors should weigh high analyst optimism against fundamental challenges.
XDTE (Roundhill S&P 500 0DTE Covered Call Strategy ETF) trades at $38.44, down 0.1% with a bearish technical signal. The ETF generates income through daily options strategies but faces concerns about net asset value erosion despite high dividend yields. Recent news highlights the fund's 32% yield but questions its sustainability as the math may not hold up over time.
The outlook remains cautious due to structural risks in the covered call strategy potentially limiting upside during market rallies. While offering frequent distributions, investors face the risk of underperforming the underlying S&P 500 index during strong bull markets. The fund's viability depends on market volatility conditions favorable to options selling strategies.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →About Roundhill S&P 500 0DTE Covered Call Strategy ETF
XDTE is an actively managed ETF that utilizes a synthetic covered call strategy on the S&P 500 Index using zero-days-to-expiration (0DTE) options. It seeks to provide high weekly income and overnight exposure to the index while mitigating some volatility through daily option premium harvesting.
Read more on XDTE →
